The Patent Finder
US

Method of Treating Chronic Kidney Disease

US 10,898,459 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Aug 18, 2025 · High confidence

Filed Nov 16, 2017 as application 15/814,767 · Granted Jan 26, 2021
Base term, 20 years from filing
Today
20 years from filing
Term ended Aug 18, 2025
2005 2026
Clock starts
Aug 18, 2005
Term ended
Aug 18, 2025
Granted
Jan 26, 2021
base term after the term ends fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
10
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Aug 18, 2005, when application 11/207,124, the earliest non-provisional in its chain, was filed (this one was filed Nov 16, 2017)Aug 18, 2025High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 1 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderAug 18, 2025High confidence

This family

Application 11/207,124Abandoned
not computed
not computed
Application PCT/US2006/032585PCT application
no patent term
no patent term
Application PCT/US2007/002151PCT application
no patent term
no patent term
Application 12/162,543Abandoned
not computed
not computed
US 10,898,459this patent
Aug 2025
Aug 2025
Application 17/119,554Abandoned
not computed
not computed
Application 17/388,361Abandoned
not computed
not computed
Application 18/123,053Abandoned
not computed
not computed
8 of 10 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 2, 2020
Reel 52295, frame 662
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCSecurity Interest
Sep 2, 2020
Reel 53671, frame 221
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCSecond Amended and Restated Intellectual Property Security Agreement
Sep 10, 2020
Reel 54173, frame 451
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCThird Amended and Restated Intellectual Property Security Agreement
Dec 17, 2020
Reel 54793, frame 455
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCFourth Amended and Restated Intellectual Property Security Agreement
Mar 30, 2021
Reel 55776, frame 491
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCFifth Amended and Restated Intellectual Property Security Agreement
May 7, 2021
Reel 56172, frame 860
Chan, Keith; Town, Winston; Globoasia, LLCPanion & BF Biotech Inc.Assignment of Assignor's Interest
May 7, 2021
Reel 56172, frame 873
Chan, Keith; Town, WinstonGloboasia, LLCAssignment of Assignor's Interest
Jun 11, 2021
Reel 56544, frame 468
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCSixth Amended and Restated Intellectual Property Security Agreement
Sep 12, 2021
Reel 57474, frame 770
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCSeventh Amended and Restated Intellectual Property Security Agreement
Dec 15, 2021
Reel 58399, frame 55
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCSecurity Interest
Jun 16, 2022
Reel 60529, frame 168
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCTenth Amended and Restated Intellectual Property Security Agreement
Aug 22, 2022
Reel 61297, frame 238
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCEleventh Amended and Restated Intellectual Property Security Agreement
Nov 29, 2022
Reel 62012, frame 561
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCTwelfth Amended and Restated Intellectual Property Security Agreement
Mar 29, 2023
Reel 63189, frame 65
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCThirteenth Amended and Restated Intellectual Property Security Agreement
Jan 4, 2024
Reel 66205, frame 143
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCFifteenth Amended and Restated Intellectual Property Security Agreement
Jan 29, 2024
Reel 66377, frame 741
Biopharma Credit PLCAkebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Termination and Release of Security Interest in Patents
Jan 29, 2024
reel/frame not recorded
Biopharma Credit PLCAkebia Therapeutics, Inc.Termination and Release of Security Interest in Patents
Jan 29, 2024
reel/frame not recorded
Biopharma Credit PLCKeryx Biopharmaceuticals, Inc.Termination and Release of Security Interest in Patents
Jun 25, 2024
Reel 67839, frame 134
Biopharma Credit PLCAkebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Termination and Release of Security Interest in Patents
Jun 25, 2024
reel/frame not recorded
Biopharma Credit PLCAkebia Therapeutics, Inc.Termination and Release of Security Interest in Patents
Jun 25, 2024
reel/frame not recorded
Biopharma Credit PLCKeryx Biopharmaceuticals, Inc.Termination and Release of Security Interest in Patents

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited